>> OPEN TOOL

    BenevolentAI is an AI-powered drug discovery company that uses its biomedical knowledge graph and machine learning to identify novel disease targets and drug candidates across multiple therapeutic areas. It has an internal drug pipeline and provides platform access to pharmaceutical partners.

    Category

    Healthcare

    Subcategory

    Drug Discovery

    Free Tier

    Not available yet

    Paid Plans

    Pharma partnership licensing

    API Cost

    Not available yet

    Web App

    BenevolentAI Trust & Security Report

    Certifications, AI-training posture, and security controls, with sourced proof.

    VIEW
    GDPR

    Verified against BenevolentAI's own trust and security pages. See the full report for sourced proof →

    Region

    Multi-region: United Kingdom, EU, and United States (with trusted suppliers). Uses Standard Contractual Clauses (SCCs) for international transfers.

    Trains on Data

    No

    Self-hostable

    No

    Discovering novel drug targets from scientific literature miningPredicting drug repurposing opportunities for rare diseasesPharmaceutical partnerships for target validationEarly-stage drug pipeline development in oncology and neurodegenerationBuilding biomedical knowledge graphs for drug discovery

    // MORE IN DRUG DISCOVERY

    Recursion Pharmaceuticals logoRecursion Pharmaceuticals
    Paid
    HealthcareDrug DiscoveryVerified
    #drug discovery#machine learning
    Insilico Medicine logoInsilico Medicine
    Paid
    HealthcareDrug DiscoveryVerified
    #drug discovery#generative ai
    Numerion Labs logoNumerion Labs
    Paid
    HealthcareDrug DiscoveryVerified
    #drug discovery#molecular modeling